For example, in colorectal cancer, where the role of CXCL12 expression and its association with the overall survival is controversial, our team showed that high expression of CXCL12 can increase the prognostic value of CD8 + T cell density in stage III disease (Lalos et al. 2021). Here, CD8A is linked to colorectal cancer.